Alkem Laboratories Limited (BOM:539523)
4,864.95
+24.40 (0.50%)
At close: Jun 6, 2025
Alkem Laboratories Revenue
In the fiscal year ending March 31, 2025, Alkem Laboratories had annual revenue of 129.65B INR with 2.34% growth. Alkem Laboratories had revenue of 31.44B in the quarter ending March 31, 2025, with 7.08% growth.
Revenue
129.65B
Revenue Growth
+2.34%
P/S Ratio
4.48
Revenue / Employee
7.44M
Employees
17,432
Market Cap
581.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |
Alkem Laboratories News
- 9 days ago - Stocks in focus on May 29: Bajaj Auto, Suzlon Energy, Alkem Labs, SJVN among 40 firms to report Q4 results - Business Upturn
- 3 months ago - Alkem Laboratories to acquire 100% stake in Bombay Ortho Industries - Business Upturn
- 3 months ago - Alkem Laboratories receives positive outcome from US FDA inspection at Taloja Bioequivalence Center - Business Upturn
- 3 months ago - Alkem Laboratories launches affordable generic empagliflozin in India - Business Upturn
- 3 months ago - Nomura upgrades Alkem Labs to Buy and believes that concerns around growth are in price - Business Upturn
- 4 months ago - Alkem Laboratories Ltd (BOM:539523) Q3 2025 Earnings Call Highlights: Strategic Acquisitions ... - GuruFocus
- 4 months ago - Q3 2025 Alkem Laboratories Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Alkem Laboratories acquires 100% stake in Adroit Biomed for Rs 140 crore - Business Upturn